Related Experiment Video
Updated: Jun 28, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Gonadal hormone deprivation regulates response to tibolone in neurodegenerative pathways
Andrew J McGovern1, Maria Angeles Arevalo2, Sergio Ciordia3
1Department of Biological Sciences, Faculty of Science and Engineering, University of Limerick, Limerick, Ireland.
Abstract:
Gonadal hormone deprivation (GHD) and decline such as menopause and bilateral oophorectomy are associated with an increased risk of neurodegeneration. Yet, hormone therapies (HTs) show varying efficacy, influenced by factors such as sex, drug type, and timing of treatment relative to hormone decline. We hypothesize that the molecular environment of the brain undergoes a transition following GHD, impacting the effectiveness of HTs. Using a GHD model in mice treated with Tibolone, we conducted proteomic analysis and identified a reprogrammed response to Tibolone, a compound that stimulates estrogenic, progestogenic, and androgenic pathways. Through a comprehensive network pharmacological workflow, we identified a reprogrammed response to Tibolone, particularly within "Pathways of Neurodegeneration", as well as interconnected pathways including "cellular respiration", "carbon metabolism", and "cellular homeostasis". Analysis revealed 23 proteins whose Tibolone response depended on GHD and/or sex, implicating critical processes like oxidative phosphorylation and calcium signalling. Our findings suggest the therapeutic efficacy of HTs may depend on these variables, suggesting a need for greater precision medicine considerations whilst highlighting the need to uncover underlying mechanisms.
Insights
Gonadal hormone deprivation impacts brain molecular environment, altering hormone therapy (HT) effectiveness. This study reveals Tibolone
Area of Science:
- Neuroendocrinology
- Molecular Neuroscience
- Proteomics
Background:
- Gonadal hormone deprivation (GHD) increases neurodegeneration risk.
- Hormone therapies (HTs) have variable efficacy, influenced by sex, drug, and timing.
- Brain molecular environment changes post-GHD, affecting HT response.
Purpose of the Study:
- Investigate the impact of GHD on the brain's molecular response to Tibolone.
- Identify molecular mechanisms underlying variable HT efficacy.
- Explore precision medicine approaches for HTs in neurodegeneration.
Main Methods:
- Utilized a mouse model of GHD treated with Tibolone.
- Performed proteomic analysis to identify protein changes.
- Employed network pharmacology to analyze pathway interactions.
Main Results:
- Identified a reprogrammed Tibolone response in the GHD brain.
- Discovered altered responses in neurodegeneration, cellular respiration, and homeostasis pathways.
- Found 23 proteins with GHD/sex-dependent Tibolone responses, affecting oxidative phosphorylation and calcium signaling.
Conclusions:
- Therapeutic efficacy of HTs is contingent on GHD and sex.
- Precision medicine is crucial for optimizing HTs.
- Further research is needed to elucidate underlying mechanisms of variable HT response.
More Related Videos
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
TGF - β Signaling Pathway
Drugs Affecting Neurotransmitter Synthesis
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Desensitization and Tachyphylaxis
Regulation of Hormone Secretion
Humoral...

